首页> 外文OA文献 >The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.

【2h】

The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.

机译：佐剂化疗可以省略8th TNM分期系统的阶段IB中的鳞片优势肺腺癌。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hiroyuki Ito; Haruhiko Nakayama; Takuya Nagashima; Joji Samejima; Kenji Inafuku; Daisuke Eriguchi; Kouzo Yamada; Masaki Suzuki; Tomoyuki Yokose;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients [J] . Wang Jia, Wu Nan, Lv Chao, Journal of Cancer Research and Clinical Oncology . 2019,第2期

机译：是否应患有阶段IB非小细胞肺癌接受佐剂化疗吗？ AJCC TNM分期系统阶段IB患者第8和第7版的生存比较
2. Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma [J] . Shuhui Cao, Jiajun Teng, Jianlin Xu, Thoracic cancer. . 2019,第2期

机译：切除阶段IB患者辅助化疗的价值固体主要和固体非主要肺腺癌
3. P1.16-63 The Value of Adjuvant Chemotherapy in Patients with Resected Stage IB Solid Predominant and Solid Non-Predominant Lung Adenocarcinoma [J] . S. Cao, H. Zhong, J. Xu Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P1.16-63辅助化疗的辅助化疗患者分解阶段IB固体主要和固体非主要肺腺癌患者
4. A deep learning approach to assess the predominant tumor growth pattern in whole-slide images of lung adenocarcinoma [C] . Zaneta Swiderska-Chadaj, Karolina Nurzynska, Bartlomiej Grala, Conference on Medical Imaging: Digital Pathology . 2020

机译：一种深入学习方法，以评估肺腺癌全幻灯片图像中主要肿瘤生长模式
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma [O] . Shuhui Cao, Jiajun Teng, Jianlin Xu, 2019

机译：辅助化疗在IB期实性和非实性肺腺癌切除患者中的价值
7. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma [O] . Fangfei Qian, Wenjia Yang, Rui Wang, 2018

机译：患有切除阶段IB肺腺癌患者的固体或微杂种图案的预后显着性和辅助化疗生存益处

The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.

著录项

引文网络

相似文献

相关主题

期刊订阅